Intuitive Surgical (NASDAQ:ISRG) Sets New 52-Week High at $448.10

Intuitive Surgical, Inc. (NASDAQ:ISRG) reached a new 52-week high on Monday . The company traded as high as $448.10 and last traded at $443.67, with a volume of 211869 shares traded. The stock had previously closed at $444.85.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ISRG. Stifel Nicolaus boosted their target price on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Piper Sandler increased their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Robert W. Baird reduced their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Evercore ISI increased their price target on Intuitive Surgical from $385.00 to $425.00 and gave the stock an “in-line” rating in a report on Tuesday. Finally, BTIG Research increased their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $404.79.

Intuitive Surgical Stock Performance

The stock has a 50 day simple moving average of $405.17 and a two-hundred day simple moving average of $384.28. The firm has a market cap of $155.65 billion, a PE ratio of 79.21, a price-to-earnings-growth ratio of 5.75 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the firm earned $1.00 EPS. The company’s quarterly revenue was up 11.5% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 5,318 shares of Intuitive Surgical stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the sale, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the transaction, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,956 shares of company stock worth $6,927,011. Insiders own 0.80% of the company’s stock.

Institutional Trading of Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Creekmur Asset Management LLC raised its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. Delos Wealth Advisors LLC raised its position in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. LRI Investments LLC purchased a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. Baystate Wealth Management LLC raised its position in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. Finally, MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.